Sept 20 (Reuters) – Shanghai Shen Lian Biomedical Corp : * SAYS PHASE II CLINICAL TRIAL OF UB-221 FOR CHRONIC SPONTANEOUS URTICARIA TREATMENT MEETS PRIMARY ENDPOINT Source text Further company
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Kenny Minchey threw a pair of touchdown passes and CJ Baxter ran for two more…
Sept 20 (Reuters) - Chongqing VDL Electronics Co Ltd : * SAYS KEY SHAREHOLDER PLANS…
VIDEO SHOWS: SOUNDBITES FROM PRESIDENT OF INTERNATIONAL OLYMPIC COMMITTEE KIRSTY COVENTRY SPEAKING TO MEDIA AFTER…
Koby Howard and James Peoples each scored two touchdowns as No. 14 Penn State rolled…
By Aleksandra Michalska and Nolan D. McCaskill PHILADELPHIA, Sept 19 (Reuters) - Pop star Ed…
(Adds statement from South Korean military in paragraphs 1-2, changes dateline) SEOUL, Sept 20 (Reuters)…